The authors describe an open study in 22 patients with febrile conditions of unknown origin who were treated with imipenem-cilastatin while waiting for routine laboratory and culture tests. These were done immediately at the patients' entry into hospital, after which imipenem-cilastatin treatment was started immediately, and was subsequently confirmed by the isolates and culture tests. The drug was found to be active and to eradicate the responsible organism in all cases. In addition, it was found to be easy to handle and not to give rise to side-effects or changes in laboratory tests.
Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin / Fiorentino, F; De Sena, R; Manzillo, E; Iadanza, A; Conte, M; Coppola, Mg; Galderisi, P; Arciello, Mt; Covelli, Bianca. - In: LA CLINICA TERAPEUTICA. - ISSN 0009-9074. - STAMPA. - May 31;129(4):Clin Ter.(1989), pp. 287-291.
Monotherapy, empirical and targetted, with imipenem-cilastatin in sepsis of bacterial origin.
COVELLI, BIANCA
1989
Abstract
The authors describe an open study in 22 patients with febrile conditions of unknown origin who were treated with imipenem-cilastatin while waiting for routine laboratory and culture tests. These were done immediately at the patients' entry into hospital, after which imipenem-cilastatin treatment was started immediately, and was subsequently confirmed by the isolates and culture tests. The drug was found to be active and to eradicate the responsible organism in all cases. In addition, it was found to be easy to handle and not to give rise to side-effects or changes in laboratory tests.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
